Vladimir Roudko

2.2k citations
15 papers · 846 indexed · h-index 10
Topics
Immunotherapy and Immune Responses (6 papers)Cancer Immunotherapy and Biomarkers (4 papers)RNA modifications and cancer (3 papers)

In The Last Decade

Vladimir Roudko

14 papers receiving 839 citations

Peers

Vladimir Roudko
Comparison fields: 5 of 78
  • Molecular Biology 464
  • Immunology 362
  • Oncology 323
  • Cancer Research 110
  • Pathology and Forensic Medicine 59
Replace Inge Verbrugge with:
Inge Verbrugge Netherlands
Silke Raffegerst Germany
Wadie D. Mahauad‐Fernandez United States
Akira Yuno United States
Lisa Cucolo United States
A. Miyajima Japan
Hiep Phuc Dong Norway
Boris Brill Germany
Dennis Knapp United States
Andrew Stiff United States
Vladimir Roudko relative to Inge Verbrugge Netherlands Inge Verbrugge's profile →
Citations per field
00.5×1.7×
Inge Verbrugge · 1×
Citations per year

Countries citing papers authored by Vladimir Roudko

Since Specialization
Citations

This map shows the geographic impact of Vladimir Roudko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Roudko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Roudko more than expected).

Fields of papers citing papers by Vladimir Roudko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Roudko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Roudko. The network helps show where Vladimir Roudko may publish in the future.

Co-authorship network of co-authors of Vladimir Roudko

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Roudko. A scholar is included among the top collaborators of Vladimir Roudko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Roudko. Vladimir Roudko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 0
3 15
4 52
5 85
6 121
7 69
8 1
9 1
10 97
11 104
12 61
13 114
14 122
15 3

About Vladimir Roudko

Vladimir Roudko is a scholar working on Immunology, Cancer Research and Oncology, having authored 15 papers that have together received 846 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Immunology (362 citations), Oncology (323 citations) and Cancer Research (110 citations). Vladimir Roudko has collaborated with scholars based in United States, Germany and Russia. Frequent co-authors include Nina Bhardwaj, Benjamin D. Greenbaum, Cansu Cimen Bozkus, Bertrand Séraphin, Elena Conti, J. Basquin, Mansi Saxena, Sreekumar Balan, Alexandra G. Evstafieva and Andrey B. Vartapetian. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026